Pancreatic Cancer Research

ResearcherHM HospitalesActive in the last 2 years

Jesús Rodríguez-Pascual

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3499-2912; OpenAlex author ID A5049258935. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 2 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-026-69055-2↗
  2. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Co-author DOI 10.1038/s41467-025-65811-y↗
  3. Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'. Co-author DOI 10.1038/bjc.2014.129↗
  4. A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer. Co-author DOI 10.1007/s10637-012-9822-x↗
  5. Stromal disrupting effects of nab-paclitaxel in pancreatic cancer. Co-author DOI 10.1038/bjc.2013.415↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yolanda Quijano · 3 shared papers, 2013–2014 · strength 0.10
  2. Emilio Vicente · 3 shared papers, 2013–2014 · strength 0.10
  3. Manuel M. Hidalgo · 3 shared papers, 2013–2014 · strength 0.10
  4. Antonio Cubillo · 3 shared papers, 2013–2014 · strength 0.10
  5. Carlos Plaza Hernandezv · 2 shared papers, 2013–2014 · strength 0.06
  6. Rafael Álvarez · 2 shared papers, 2013–2014 · strength 0.06
  7. Mariano Barbacid · 2 shared papers, 2013–2014 · strength 0.06
  8. Carmen E. Guerra · 2 shared papers, 2013–2014 · strength 0.06
  9. N.V. Rajeshkumar · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.